申请人:Myrexis, Inc.
公开号:US20130029942A1
公开(公告)日:2013-01-31
Disclosed are 4-arylamino-quinazolines and analogs thereof that are effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
本发明揭示了4-芳基氨基喹唑啉及其类似物,它们有效地激活半胱氨酸蛋白酶并诱导细胞凋亡。该发明的化合物在治疗各种临床病症中具有用途,其中包括发生异常细胞无控制生长和扩散的情况。